Presentation is loading. Please wait.

Presentation is loading. Please wait.

Opioid Use Disorders: Recognition and Pharmacotherapy Review

Similar presentations


Presentation on theme: "Opioid Use Disorders: Recognition and Pharmacotherapy Review"— Presentation transcript:

1 Opioid Use Disorders: Recognition and Pharmacotherapy Review
Joji Suzuki, MD Director, Division of Addiction Psychiatry Department of Psychiatry, Brigham and Women’s Hospital Assistant Professor of Psychiatry, Harvard Medical School

2 Epidemiology Update: How Did We Get Here?

3 Overview Overview of current state
Deaths caused by drug-related overdoses vs traffic accidents How we got here: three key developments Started in the early 90’s and have a direct impact in the present Non-medical or recreational use Most common opioid sources What happens after recreational use begins?

4 Overview Overview of current state
Deaths caused by drug-related overdoses vs traffic accidents How we got here: three key developments Started in the early 90’s and have a direct impact in the present Non-medical or recreational use Most common opioid sources What happens after recreational use begins?

5 Overview Overview of current state
Deaths caused by drug-related overdoses vs traffic accidents How we got here: three key developments Started in the early 90’s and have a direct impact in the present Non-medical or recreational use Most common opioid sources What happens after recreational use begins?

6 Drug-related overdoses

7 Drug-related overdoses
2014: 28,000 deaths in the US Drug-related overdoses

8 Drug-related overdoses
2014: 28,000 deaths in the US 70 deaths everyday Drug-related overdoses

9 Drug-related overdoses
Traffic accidents 2014: 28,00 deaths in the US 70 deaths everyday Drug-related overdoses

10 Drug overdoses: leading cause of accidental death
Motor vehicle accidents Drug overdoses: leading cause of accidental death Drug induced overdose

11 More deaths from prescription opioids than heroin

12 Overdose deaths/100,000 Opioid sales/10,000

13 How did we get here?

14 “Improve pain management”
Elderly, HIV patients, cancer 1980 1990 2000

15 1990 “Improve pain management” Elderly, HIV patients, cancer
“Opioids? Be careful” 1980 1990 2000

16 1990 “Improve pain management” Elderly, HIV patients, cancer
“Opioids? Be careful” Changes 1980 1990 2000

17 Pain assessment “Fifth vital sign”

18 Greater opioid utilization
Pain assessment Greater opioid utilization “Fifth vital sign”

19 Pain assessment “Fifth vital sign”
Greater opioid utilization “Fifth vital sign” Insufficient training in multimodal treatment

20 Unethical Marketing Unethical Marketing
“Non-addictive version of short-acting oxycodone” Oxycontin (Oxycodone CR) (1996)

21 Unethical Marketing Unethical Marketing No evidence to support claim
“Non-addictive version of short-acting oxycodone” No evidence to support claim Oxycontin (Oxycodone CR) (1996)

22 Non-medical use Unused opioids

23 Non-medical (recreational) use:
Opioids used for purposes other than they were prescribed Self-medicate negative moods Self-medicate insomnia Enjoy euphoria Diversion Snorting

24 Non-medical (recreational) use:
Opioids used for purposes other than they were prescribed Self-medicate negative moods Self-medicate insomnia Enjoy euphoria Diversion Snorting

25 Source of misused prescription opioids
SAMHSA, 2013

26 SAMHSA, 2013

27 Some will be able to stop
Escalation Heroin is much cheaper Physical withdrawal Strong cravings Financially challenging Overdose risk increases dramatically Snorting Injecting

28 Some will be able to stop
Escalation Heroin is much cheaper Physical withdrawal Strong cravings Financially challenging Overdose risk increases dramatically Snorting Injecting

29 Some will be able to stop
Escalation Heroin is much cheaper Physical withdrawal Strong cravings Financially challenging Overdose risk increases dramatically Snorting Injecting

30 Some will be able to stop
Escalation Heroin is much cheaper Physical withdrawal Strong cravings Financially challenging Overdose risk increases dramatically Snorting Injecting

31 Some will be able to stop
Escalation Transition to heroin Physical withdrawal Strong cravings Financially challenging Overdose risk increases dramatically Snorting Injecting

32 Some will be able to stop
Escalation Transition to heroin Physical withdrawal Strong cravings Financially challenging Overdose risk increases dramatically Snorting Injecting

33 Illicitly produced fentanyl
Cheap Widely available Incorporated into heroin Counterfeit tablets Many patients have no idea they are using it

34 Illicitly produced fentanyl
Cheap Widely available Incorporated into heroin Counterfeit tablets Many patients have no idea they are using it

35 Illicitly produced fentanyl
Cheap Widely available Incorporated into heroin Counterfeit tablets Many patients have no idea they are using it

36 Key Points Drug overdoses: now the leading cause of accidental death
Overdose deaths linked to increase in opioid prescriptions Drug diversion Most common source: family and friends Most of these prescriptions come from a single doctor Recreational use Some individuals will escalate Some of them even up to IV heroin

37 Key Points Drug overdoses: now the leading cause of accidental death
Overdose deaths linked to increase in opioid prescriptions Drug diversion Most common source: family and friends Most of these prescriptions come from a single doctor Recreational use Some individuals will escalate Some of them even up to IV heroin

38 Key Points Drug overdoses: now the leading cause of accidental death
Overdose deaths linked to increase in opioid prescriptions Drug diversion Most common source: family and friends Most of these prescriptions come from a single doctor Recreational use Some individuals will escalate Some of them even up to IV heroin

39 Key Points Drug overdoses: now the leading cause of accidental death
Overdose deaths linked to increase in opioid prescriptions Drug diversion Most common source: family and friends Most of these prescriptions come from a single doctor Recreational use Some individuals will escalate Some of them even up to IV heroin


Download ppt "Opioid Use Disorders: Recognition and Pharmacotherapy Review"

Similar presentations


Ads by Google